Feb 7, 2026
What is the FDA process for approving Alzheimer’s drugs and how can consumers verify approvals?
The evaluates drugs through either traditional (full) approval or the Accelerated Approval pathway; the latter allows earlier market access when a drug affects a surrogate endpoint “reasonably likely ...